Cargando…

Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country

Although BRCA1/2 genetic testing in developed countries is part of the reality for high-risk patients for hereditary breast and ovarian cancer (HBOC), the same is not true for upper-middle-income countries. For that reason, this study aimed to evaluate whether the BRCA1/2 genetic test and preventive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lourenção, Marina, Simões Correa Galendi, Julia, Galvão, Henrique de Campos Reis, Antoniazzi, Augusto Perazzolo, Grasel, Rebeca Silveira, Carvalho, André Lopes, Mauad, Edmundo Carvalho, de Oliveira, Jorge Henrique Caldeira, Reis, Rui Manuel, Mandrik, Olena, Palmero, Edenir Inêz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309566/ https://www.ncbi.nlm.nih.gov/pubmed/35898894 http://dx.doi.org/10.3389/fonc.2022.951310

Ejemplares similares

Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer
por: Felicio, Paula Silva, et al.
Publicado: (2016)

Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system
por: Arruda, Gustavo Viani, et al.
Publicado: (2022)

Genetic alterations detected by comparative genomic hybridization in BRCAX breast and ovarian cancers of Brazilian population
por: Felicio, Paula Silva, et al.
Publicado: (2018)

Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital
por: Palmero, Edenir I., et al.
Publicado: (2016)

Differential Profile of BRCA1 vs. BRCA2 Mutated Families: A Characterization of the Main Differences and Similarities in Patients
por: Fernandes, Gabriela Carvalho, et al.
Publicado: (2019)

Whole‐exome sequencing of non‐BRCA1/BRCA2 mutation carrier cases at high‐risk for hereditary breast/ovarian cancer
por: Felicio, Paula S., et al.
Publicado: (2020)

Genomic rearrangements in BRCA1 and BRCA2: A literature review
por: Ewald, Ingrid Petroni, et al.
Publicado: (2009)

Using Co-segregation and Loss of Heterozygosity Analysis to Define the Pathogenicity of Unclassified Variants in Hereditary Breast Cancer Patients
por: Grasel, Rebeca Silveira, et al.
Publicado: (2020)

Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome
por: dos Santos, Wellington, et al.
Publicado: (2022)

Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system
por: Lourenção, Marina, et al.
Publicado: (2023)

miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
por: Pessôa-Pereira, Danielle, et al.
Publicado: (2020)

Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes
por: Fernandes, Gabriela C., et al.
Publicado: (2016)

New insights on familial colorectal cancer type X syndrome
por: Garcia, Felipe Antonio de Oliveira, et al.
Publicado: (2022)

Identification of hereditary cancer in the general population: development and validation of a screening questionnaire for obtaining the family history of cancer
por: Campacci, Natalia, et al.
Publicado: (2017)

Insights on variant analysis in silico tools for pathogenicity prediction
por: Garcia, Felipe Antonio de Oliveira, et al.
Publicado: (2022)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
por: Gomes, Renan, et al.
Publicado: (2020)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Prostate cancer screening among elderly men in Brazil: should we diagnose or not?
por: Mori, Rafael Ribeiro, et al.
Publicado: (2020)

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2016)

Sequencing technology status of BRCA1/2 testing in Latin American Countries
por: Solano, Angela R., et al.
Publicado: (2020)

The Brazilian TP53 mutation (R337H) and sarcomas
por: Volc, Sahlua Miguel, et al.
Publicado: (2020)

Development and validity of a questionnaire to test the knowledge of primary care personnel regarding nutrition in obese adolescents
por: de Pinho, Lucinéia, et al.
Publicado: (2013)

Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2022)

Data on Utility in Cost–Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
por: Palmero, Edenir Inêz, et al.
Publicado: (2020)

Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer
por: Simoes Correa-Galendi, Julia, et al.
Publicado: (2020)

Expectations for the Development of Health Technology Assessment in Brazil
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Serum Predose Metabolic Profiling for Prediction of Rosuvastatin Pharmacokinetic Parameters in Healthy Volunteers
por: Silveira, Anne Michelli Reis, et al.
Publicado: (2021)

Pediatric ventilation weaning
por: Lourenção, Murilo Lopes, et al.
Publicado: (2020)

Hemophagocytic lymphohistiocytosis secondary to visceral leishmaniasis in an endemic area in the north of Minas Gerais, Brazil
por: de Carvalho, Fernando Henrique Guimarães, et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil
por: Cotrim, Deborah Porto, et al.
Publicado: (2019)

Mechanisms and role of microRNA deregulation in cancer onset and progression
por: Palmero, Edenir Inês, et al.
Publicado: (2011)

Analysis of Survival Rates of Patients Diagnosed With Incipient Esophagic Cancer
por: Mauad, Edmundo Carvalho, et al.
Publicado: (2010)

FAMMO(CN) – Demonstration and evaluation of a framework for the multidisciplinary assessment of organisational maturity on business continuity
por: Russo, Nelson, et al.
Publicado: (2022)

Effectiveness of screening for oral cancer and oral potentially malignant disorders (OPMD): A systematic review
por: Parak, Uzayr, et al.
Publicado: (2022)

Digital photography in skin cancer screening by mobile units in remote areas of Brazil
por: Silveira, Carlos Eduardo Goulart, et al.
Publicado: (2014)

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial
por: de Pádua Souza, Cristiano, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e6mq7ijqr8iqpaogcn3tnlf0st